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Gastric adenoma is an important premalignant lesion. The 
annual incidence of gastric cancer is 0.6% for patients with 
mild to moderate dysplasia and 6% for those with severe dys-
plasia.1 Differentiated or intestinal-type carcinoma, rather than 
the diffuse type, is mainly associated with this carcinogenic 
pathway.2 Recently, Choi et al.3 detected pre-existing adenoma 
in 15.6% of endoscopically resected early gastric cancer (EGC), 
and EGC with pre-existing adenoma showed a greater associa-
tion with Helicobacter pylori-related chronic inflammation than 
EGC without pre-existing adenoma. Regarding the treatment 
of adenoma, particularly with low-grade dysplasia (LGD), there 
is controversy over whether to treat all LGD or selectively treat 
LGD with risk factors. Since the diagnosis of gastric adenoma 
with LGD in Korea carries a substantial risk of developing 
cancer,4 gastric adenomas with either LGD or high-grade dys-
plasia (HGD) are usually resected endoscopically. However, no 
treatment strategy has been established for mixed lesions with 
gastric cancer and adenoma, since gastric cancer derived from 
the adenoma-carcinoma sequence is less frequent.5 Most studies 
have focused on differentiating between adenoma and cancer 
and how to reduce the histological discrepancy rate between the 
results of endoscopic forceps biopsy and endoscopic resection 
(ER).6,7
The article published in Gut and Liver, “Gastric cancer caused 
by adenoma: predictive factors associated with lesions other 
than the expanded indications” by Park et al.8 started from the 
question, “Can the current indications for curative ER of gastric 
cancer be applied to the gastric cancer caused by adenoma?” 
They also investigated the predictors of which lesions exceed 
the expanded indications for ER. They analyzed 342 patients 
diagnosed with gastric cancer caused by adenoma who un-
derwent ER. The resected specimens were sectioned and each 
tissue slice was then examined to determine the extent of tu-
mor involvement and the borders of the tumors. Patients with 
adenomatous components at the margin of the carcinoma were 
defined as cancers arising from adenomas. The overall curative 
resection rate was 92.7%; it was 100% (185/185) for lesions 
meeting the absolute indications, 98.3% (118/120) for lesions 
meeting the expanded indications, and 0% (0/22) for lesions 
exceeding the expanded indications. The overall rate of lymph 
node metastasis was 0.3% (1/327): 0% (0/185) in the absolute 
group, 0% (0/118) in the expanded group, and 4.5% (1/22) in 
the beyond the expanded group. A gross tumor size 3 cm and 
carcinoma component 35% were independently associated 
with lesions beyond the expanded indications. Unlike the previ-
ous studies, Park et al.8 focused on the treatment of EGC caused 
by adenoma. They demonstrated that the current indications for 
curative ER of EGC can be applied to gastric cancer arising from 
adenoma, and there are some predictive values for non-curative 
resection. The treatment of lesions with mixed adenoma and 
EGC has been based on the indications of ER for EGC. However, 
no study has evaluated whether the current indications for ER 
are indeed applicable to EGC caused by adenoma, and the treat-
ment outcome has not been evaluated. Park et al.8 is meaningful 
in that it is the first study to provide a guide for the resection of 
EGC caused by adenoma, and parameters associated with non-
curative resection.
However, we regret that no further study using tissue map-
ping was performed. As the authors mentioned, each slide was 
examined on mapping paper to identify the tumor borders and 
showed cancer in the red area and adenoma in the blue area. 
On analyzing the tissue that they presented in this study, some 
 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) 
which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Endoscopic Resection of Gastric Cancer Caused by Adenoma 
Seung Yong Shin and Jie-Hyun Kim
Department of Internal Medicine, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Korea
See “Gastric Cancer Caused by Adenoma: Predictive Factors Associated with Lesions Other Than the Expanded Indications” 
by Seong Hwan Park, et al. on page 246, Vol. 12. No. 3, 2018
Correspondence to: Jie-Hyun Kim
Department of Internal Medicine, Gangnam Severance Hospital, Yonsei University College of Medicine, 211 Eonju-ro, Gangnam-gu, Seoul 06273, 
Korea
Tel: +82-2-2019-3505, Fax: +82-2-3463-3882, E-mail: otilia94@yuhs.ac
pISSN 1976-2283  eISSN 2005-1212  https://doi.org/10.5009/gnl18161
220  Gut and Liver, Vol. 12, No. 3, May 2018
red areas indicating cancers were concentrated together, based 
on Fig. 2, although the authors stated that most cancers were 
distributed in a mosaic pattern. Concentrated red areas may be 
observed in other cases. These areas have important implica-
tions for the study of adenoma and EGC. Previous studies of 
the histological discrepancy between adenoma and EGC have 
focused mainly on the endoscopic findings. To our knowledge, 
no studies have been based on mapping resected tissue.9,10 
Therefore, another impressive outcome might be expected by 
comparing the endoscopic findings and maps of cancerous and 
non-cancerous compartments.
This study upset our concept of the curative resection of ad-
enoma that was upgraded to cancer after ER. Kim et al.6 had 
reported that 18.7% of gastric LGD showed upgraded histology 
after ER. Most endoscopists believed that the lesions that were 
upgraded to EGC after ER were usually included in the cura-
tive resection, since they are thought to be an early cancerous 
change. However, in addition to the curative resection rate, 
Park et al.8 showed that about 6.6% of the patients had lesions 
beyond the expanded indications. Although the results of endo-
scopic forceps biopsies were reported as adenoma, lesions with a 
gross tumor size 3 cm and a carcinoma component 35% can 
be included in non-curative resection. This suggests that careful 
selection of the patients for ER is essential to reduce the risks 
associated with an unnecessary procedure. This study provides 
important data that should help with the treatment strategy for 
EGC caused by adenoma. Since the ultimate goals for the treat-
ment of EGC caused by adenoma are not only curative resection 
but also preventing unnecessary ER, further studies must vali-
date other parameters associated with non-curative resection.
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